Increasing research and development and improving investment in healthcare in developing countries further promote mesalamine market growth.

Description

Mesalamine Market will reach USD 4.4 billion by 2025

Mesalamine Market: by Product Type (Glass Bottle, Glass Jars, Glass Vials and Candle Mesalamines), by Application (Cosmetics & Perfumes, Pharmaceuticals, Food Packaging, Beverage Packaging) – Global Industry Sizing, Growth, Trend, Opportunity, and Forecast (2020–2025)

Get Free Sample Copy @ https://www.marketstatsville.com/request-sample/Mesalamine-Market

The mesalamine market report covers a thorough analysis of the market dynamics, business models, segmental/regional analysis, and respective market shares and strategies adopted by the key market players operating in the global market. It entails an in-depth analysis of the factors influencing the global market and market statistics indicating region wise and segment-wise market share/growth analysis. The study of the report will outlook one of the most exhaustive analysis of the market, capturing all the aspects of the mesalamine market.

Mesalamine: Market Introduction

Mesalamine, also known as Mesalazine, is a prescription drug containing 5-aminosalicylic acid that helps cure ulcerative colitis (UC) and other inflammatory bowel disorders. Mesalamine is known as the first-line agent for the treatment of active UC and preservation of clinical recovery. It has been reported as the active anti-inflammatory agent and has been used since the 1940s to treat UC. There are several different types of mesalamine medications that can be distinguished based on their means of delaying mesalamine release until it reaches the colon.

Get full report in 24 hours in your inbox @ https://www.marketstatsville.com/Mesalamine-Market

Mesalamine: Market Dynamics

Mesalamine is usually very safe, and patients handle it very well. High global occurrence of Ulcerative Colitis (UC) is estimated to fuel the demand for mesalamine. New product releases are also expected to foresee the growth of the market.

Growing patient support programs are providing numerous opportunities for the global Mesalamine market. Increasing research and development and improving investment in healthcare in developing countries further promote mesalamine market growth. New partnerships and ventures have opened the way for market players to grow the business and customer base.

The factors that raise restraints on the global mesalamine market are side effects of treatments and medications that cause nausea or vomiting, fever, headache, stomach and abdominal pain, and rash. It may also increase the permeability of pancreatic ducts. The high level of unaddressed clinical need in ulcerative colitis hampers global mesalamine market growth.

Impact of COVID 19 on Mesalamine Market-  

Due to the COVID-19 outbreak, many industries are suffering from many issues such as a halt in production, lack of supply of raw material due to the imposition of lockdown in various nations. The COVID-19 has significantly impacted the petrochemical industry and jolted the global economy. With the halt in construction projects, especially during April-May 2020, the demand for mesalamine declined from the end-use industries. This is expected to impact the overall market value of mesalamine in 2020.

Scope of the Report

The report outlines the study of the Mesalamine market on the basis of dosage and application.

Based on the dosage form, the Mesalamine market is segmented into-

• Capsule
• Tablets

Based on application, the Mesalamine market is segmented into-

• Ulcerative colitis
• Crohn's disease
• Other bowel inflammatory diseases

Mesalamine Market: Regional Outlook

The global mesalamine market has been segmented into five geographical regions, namely, North America, Asia Pacific, South America, Europe, and the Middle East and Africa. North America is the largest mesalamine market due to the presence of major pharmaceutical firms in the region. Government funding and incentives for the development of new and alternative therapeutics for the treatment is also boosting the mesalamine market growth. Europe region shares the highest revenue as the prevalence of bowel diseases increasing across the region

Mesalamine Market: Competitive Landscape

The major companies in the global Mesalamine market are Mylan N.V., Teva Pharmaceuticals, Ferring B.V., Allergan, Bausch Health Companies Incorporated (Salix Pharmaceutical).

The other major companies include Zydus Cadila, Cosmo Pharmaceuticals, Tillotts Pharma AG, Shire plc, Pfizer Incorporated, Norga Pharma, AstraZeneca, Abbvie Incorporated, Takeda Pharmaceuticals, Johnson and Johnson, Boehringer Ingelheim GmbH, Sandoz Mesalamine, Cipla, Synmosa Biopharma Corporation, Lunan Better Pharmaceuticals, Merck & Co, Novartis AG.

The mesalamine market report provides a thorough analysis of macro-economic factors along with market attractiveness of every segment. The report will include an in-depth qualitative and quantitative assessment of segmental/regional outlook with the presence of the market players in the respective segment and region/country. The information concluded in the report includes the inputs from industry participants and industry experts across the value chain.

Browse complete report@ https://www.marketstatsville.com/Mesalamine-Market

About US: 

Market Statsville Group (MSG) is a full-service market research and business consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. MSG has an entire repository of research reports on more than 2,000 niche industries and more than 12,000 company profiles

Contact Information:

Contact US:
Eric Martin
Corporate Sales Specialist, USA
Market Statsville Group
USA: +1-580-205-2707 | India: +91-702-496-8807
Email: sales@marketstatsville.com
Web: https://marketstatsville.com/